A wee reminder that today I will be taking part in a webinar organised by The Conversation on the topic of “Living with coronavirus vaccine”. You can watch it live via these links on either Facebook, YouTube or Twitter from 4pm GMT on December 1.
Wee means “small” or “little” in Scotland, so this is a “little” reminder.
An interesting discussion about the AstraZeneca – Oxford vaccine. Moderna and Pfizer/BioNTech were very clear with the protocol and with the reporting. I described the details of the statistical basis of the trials in The Conversation article. Moderna group even released a very detailed report on side effects.
In contrast, the Oxford trial seems to have been conducted in a less rigorous way and we are missing the data to analyse it in the same detail. The 62% to 90% efficacy switch with 1/2 dose at the first treatment will need more study; it has been reported that the “optimal” dose has only been given to 2,3oo people and there were issues with who received the “optimal dose”.
This just stresses how important it is to understand the statistical details behind the vaccine trials. None of the trials addressed long-term efficacy and safety, and the efficacy (and safety) in different age/vulnerability groups are still open.
The Conversation UK, an online publisher of popular scientific articles, is organising a webinar on the subject of the coronavirus vaccine:
Strathclyde will be represented by my colleague, Dr Lynn Williams, and your humble correspondent. It should be both a fun and interesting experience.
Click here to register and you will be sent joining instructions before the event. The event is free to attend and you get an opportunity to ask questions!